Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma
Sijie Lin, Kuancan Liu, Yongchun Zhang, Ming Jiang, Rong Lu, Christopher J. Folts, Xia Gao, Mark D. Noble, Tingting Zhao, Zhongren Zhou, Xiaopeng Lan, Jianwen Que
Dive into the research topics of 'Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma'. Together they form a unique fingerprint.